Fig. 4From: Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinomaChange in liver function, as measured by the global liver uptake rate (%/min) from 99mTc-mebrofenin dynamic scintigraphy, with the mean absorbed dose to healthy liver parenchyma following SIRT (R2 of linear fit is 0.104)Back to article page